As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world’s first single-dose shots against the deadly mosquito-borne disease.
Dengue, which causes severe flu-like symptoms and debilitating body aches, has exploded globally, fueled by rising temperatures and densely populated cities.
The WHO said that almost half of the world’s population is now at risk, with 100 million to 400 million infections every year. India alone has recorded more than 1 million cases and at least 1,500 deaths since 2021.
Photo: AFP
Hoping to stem the global epidemic, Panacea Biotec has begun the final and third phase of trials for its vaccine, DengiAll, which it has been pursuing for nearly 15 years. More than 10,000 volunteers across the country are enrolled in the study, overseen by the Indian Council of Medical Research, with the vaccine on track for rollout as early as next year if the trial results are favorable.
“We will try to get this vaccine out there as soon as possible,” Panacea chief scientific officer Syed Khalid Ali said.
Monsoon outbreaks regularly push Indian hospitals to their limits, crowding urban wards and leaving rural regions grappling with late diagnoses and poor access to care.
Higher temperatures and changing rainfall patterns create ideal conditions for Aedes mosquitoes — the vectors of dengue — to reproduce and spread the virus.
Children are particularly vulnerable to the more severe form, called dengue hemorrhagic fever, as they are more likely to suffer low platelet counts and shock.
Participants in the phase three trials, which started in 2024, were randomly assigned to receive either the vaccine or a placebo, with the results expected later this year.
Vaccines against all four dengue serotypes have long posed a scientific challenge. Immunity to one strain does not protect against others, and secondary infections could be more severe. Most existing candidates require multiple doses.
If approved, DengiAll would become one of the world’s first single-dose dengue vaccines, following Brazil’s approval of a similar shot last year. It would also be the first such vaccine available in India, where no dengue shot is licensed for public use.
Inside the Panacea’s research labs, doctor Priyanka Priyadarsiny, head of biological research and development, said vaccine development involves several steps, from proof-of-concept studies to regulatory checks.
“We are extremely cautious about purity, safety and adverse effects,” she said. “Only after meeting regulatory specifications can a product be considered safe for public use.”
The WHO recommends only one dengue vaccine, Qdenga, produced by Japan’s Takeda for children aged six to 16 in high-transmission settings. Qdenga, which requires two doses administered three months apart, is not available in India.
Ali said DengiAll could be given to people aged one to 60 and is expected to offer long-term protection.
In India, final approval would come from the Drugs Controller General of India, while WHO prequalification would be required for large-scale international use.
Experts said a successful Indian vaccine could be key to affordability and mass rollout in lower-income countries.
Virologist and Oxford University fellow Shahid Jameel — who is not connected with the trial — warned that dengue incidence could rise by 50 percent to 75 percent by 2050 given climate change trends.
Still, he cautioned that only phase three results would determine whether a candidate meets the criteria for a safe and effective dengue vaccine.
“Phase III testing and follow-up are needed to show if the above conditions are met,” he said. “Only then can we have a useful dengue vaccine. It is still early days, but there is hope for the future.”
THE TRAGEDY OF PUNCH: Footage of the seven-month-old Japanese macaque has gone viral online after he was rejected by his mother and formed a bond with a soft toy A baby monkey in Japan has captured hearts around the world after videos of him being bullied by other monkeys and rejected by his mother went viral last week. Punch, a Japanese macaque, was born in July last year at Ichikawa City Zoo. He has drawn international attention after zookeepers gave him a stuffed orangutan toy after he was abandoned by his mother. Without maternal guidance to help him integrate, Punch has turned to the toy for comfort. He has been filmed multiple times being dragged and chased by older Japanese macaques inside the enclosure. Early clips showed him wandering alone with
Australian Prime Minister Anthony Albanese yesterday said he did not take his security for granted, after he was evacuated from his residence for several hours following a bomb threat sent to a Chinese dance group. Albanese was evacuated from his Canberra residence late on Tuesday following the threat, and returned a few hours later after nothing suspicious was found. The bomb scare was among several e-mails threatening Albanese sent to a representative of Shen Yun, a classical Chinese dance troupe banned in China that is due to perform in Australia this month, a spokesperson for the group said in a statement. The e-mail
‘OCCUPATION’: Hong Kong said it had lodged ‘stern protests’ with Panama’s consulate, and would ‘staunchly support’ the rights and interests of Hong Kong companies Panamanian President Jose Raul Mulino on Monday ordered the temporary occupation of two ports run by a unit of CK Hutchison Holdings Ltd following the Supreme Court’s ruling against the firm’s concession, escalating a dispute that has become a proxy battle between the US and China in Latin America. Mulino said in a speech that the administration and operation of the two ports on the strategic Panama Canal is to revert to the country’s National Maritime Authority to ensure their uninterrupted, safe and efficient operation. The occupation covers movable equipment at the ports and does not mean a definitive loss of
GAME CHANGER The Russian invasion of Ukraine has shown the utility of small drones for recon, for supporting logistics and for killing across the modern battlefield Five European nations have announced a new program to produce low-cost air defense systems and autonomous drones using Ukrainian expertise, hard-won over the past four years fighting against Russia. Friday’s initiative of the five nations — France, Poland, Germany, the UK and Italy — comes as one of many European efforts to bolster defense along their borders, like a “drone wall ” with Russia and Ukraine to better detect, track and intercept drones violating Europe’s airspace. Both Moscow and Kyiv have cutting-edge drone warfare capabilities forged in the grim laboratory of war where battlefield innovations have rewritten modern battle tactics. Poland is
RSS